(Q45979796)

18 December 2017

title

Immunotoxicity profile of natalizumab. (English)

1 reference

18 December 2017

author name string

Nancy G Wehner

1

1 reference

18 December 2017

Carolyn Gasper

2

1 reference

18 December 2017

George Shopp

3

1 reference

18 December 2017

Joyce Nelson

4

1 reference

18 December 2017

Ken Draper

5

1 reference

18 December 2017

Suezanne Parker

6

1 reference

18 December 2017

Janet Clarke

7

1 reference

18 December 2017

publication date

1 June 2009

1 reference

18 December 2017

Journal of Immunotoxicology

published in

1 reference

18 December 2017

volume

6

1 reference

18 December 2017

issue

2

1 reference

18 December 2017

page(s)

115-129

1 reference

18 December 2017

Distinct changes in adult lymphopoiesis in Rag2-/- mice fully reconstituted by alpha4-deficient adult bone marrow cells

cites work

1 reference

https://api.crossref.org/works/10.1080%2F15476910902977381

Adhesion molecules in inflammatory bowel disease: therapeutic implications for gut inflammation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15476910902977381

Natalizumab for active Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15476910902977381

A randomized placebo-controlled trial of a humanized monoclonal antibody to alpha4 integrin in active Crohn's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15476910902977381

Human cytomegalovirus induces JC virus DNA replication in human fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15476910902977381

Natalizumab therapy for moderate to severe Crohn disease in adolescents

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15476910902977381

Progressive multifocal leukoencephalopathy complicating treatment with natalizumab and interferon beta-1a for multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15476910902977381

Progressive multifocal leukoencephalopathy in a patient treated with natalizumab

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15476910902977381

Hematopoiesis: wandering progenitor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15476910902977381

A controlled trial of natalizumab for relapsing multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15476910902977381

VLA-4-mediated interactions between normal human hematopoietic progenitors and stromal cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15476910902977381

A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15476910902977381

Distinct roles of integrins alpha6 and alpha4 in homing of fetal liver hematopoietic stem and progenitor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15476910902977381

Natural killer (NK)-resistant human lung cancer cells are lysed by recombinant interleukin-2-activated NK cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15476910902977381

Alpha4 integrins and the immune response

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15476910902977381

Natalizumab plus interferon beta-1a for relapsing multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15476910902977381

Natalizumab Induction and Maintenance Therapy for Crohn's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15476910902977381

Safety and tolerability of concurrent natalizumab treatment for patients with Crohn's disease not in remission while receiving infliximab.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15476910902977381

Posttransplant lymphoproliferative disorder associated with an Epstein-Barr-related virus in cynomolgus monkeys.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15476910902977381

Progressive multifocal leukoencephalopathy after natalizumab therapy for Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15476910902977381

Absolute numbers of lymphocytes subsets migrating through the compartments of the normal and transplanted rat spleen

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15476910902977381

Evaluation of patients treated with natalizumab for progressive multifocal leukoencephalopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15476910902977381

10.1080/15476910902977381

21 January 2018

Identifiers

DOI

1 reference

18 December 2017

1 reference

18 December 2017